NCT04996004 A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma Status TERMINATED Phase PHASE2
NCT04987944 Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma Status TERMINATED Phase PHASE1
NCT04987931 Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast Cancer Status COMPLETED Phase N/A
NCT04985266 A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer Status RECRUITING Phase PHASE2
NCT04983264 A Study to Evaluate GBT021601-012 Single Dose and Multiple Dose in Participants With Sickle Cell Disease (SCD) Status COMPLETED Phase PHASE1
NCT04982848 Korea Post Marketing Surveillance (PMS) Study of Talzenna® Status NOT_YET_RECRUITING Phase N/A
NCT04979988 Study to Evaluate Clinical Real World Outcomes of Lorlatinib After Alectinib in ALK-Positive NSCLC Japanese Patients Status COMPLETED Phase N/A
NCT04974294 PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2) Status UNKNOWN Phase PHASE4
NCT04973826 Study to Assess the Pharmacokinetics, Safety and Tolerability of Aztreonam-Avibactam in Healthy Chinese Participants. Status COMPLETED Phase PHASE1
NCT04969419 Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo Status COMPLETED Phase N/A
NCT04967443 Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer for Prazosin Hydrochloride Capsules Status COMPLETED Phase PHASE1
NCT04966481 Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor Status RECRUITING Phase PHASE3
NCT04962230 Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir Status COMPLETED Phase PHASE1
NCT04962022 Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants Status COMPLETED Phase PHASE1
NCT04960202 EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19 Status COMPLETED Phase PHASE2/PHASE3
NCT04955626 To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. Status COMPLETED Phase PHASE3
NCT04951323 Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo) Status UNKNOWN Phase PHASE3
NCT04937660 Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC Status COMPLETED Phase N/A